Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: Concurrent expression in cancer cells from primary tumour and metastatic lymph node

被引：61
作者：
Saintigny, Pierre
Kambouchner, Marianne
Ly, Madani
Gomes, Noelia
Sainte-Catherine, Odile
Vassy, Roger
Czernichow, Sebastien
Letoumelin, Philippe
Breau, Jean-Luc
Bernaudin, Jean-Francois
Kraemer, Michel
机构：
[1] Hop Avicenne, Med Oncol Serv, AP HP, F-93009 Bobigny, France
[2] Univ Paris 13, Lab Oncol Cellulaire & Mol, EA 3410, Bobigny, France
[3] Hop Avicenne, Serv Anat & Cytol Pathol, AP HP, F-93009 Bobigny, France
[4] Univ Paris 06, Hop Tenon, Serv Histol Biol Tumorale, EA 3499, Paris, France
[5] Hop Avicenne, AP HP, Bobigny, France
[6] Hop Avicenne, Dept Interhosp Sante Publ, AP HP, Bobigny, France
来源：
LUNG CANCER | 2007年 / 58卷 / 02期
关键词：
vascular endothelial growth factor-C;
D O I：
10.1016/j.lungcan.2007.06.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Introduction: Investigation of the role of vascular endothelial growth factor-C (VEGF-C) and VEGF receptor-3 (VEGFR-3) in non-small-cell lung cancer (NSCLC) has mainly focused on lymph node (LN) metastasis related to lymphangiogenesis. However, the coexpression of VEGF-C/VEGFR-3 by tumour cells can independently play an important role.
引用
收藏
页码：205 / 213
页数：9
相关论文
共 36 条
[31]   The role of the VEGF-C/VEGFR-3 axis in cancer progression [J].
Su, J-L ;
Yen, C-J ;
Chen, P-S ;
Chuang, S-E ;
Hong, C-C ;
Kuo, I-H ;
Chen, H-Y ;
Hung, M-C ;
Kuo, M-L .
BRITISH JOURNAL OF CANCER, 2007, 96 (04) :541-545
[32]   The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells [J].
Su, JL ;
Yang, PC ;
Shih, JY ;
Yang, CY ;
Wei, LH ;
Hsieh, CY ;
Chou, CH ;
Jeng, YM ;
Wang, MY ;
Chang, KJ ;
Hung, MC ;
Kuo, ML .
CANCER CELL, 2006, 9 (03) :209-223
[33]   The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer [J].
Takizawa, H. ;
Kondo, K. ;
Fujino, H. ;
Kenzaki, K. ;
Miyoshi, T. ;
Sakiyama, S. ;
Tangoku, A. .
BRITISH JOURNAL OF CANCER, 2006, 95 (01) :75-79
[34]   Tumor-induced lymphangiogenesis: A target for cancer therapy? [J].
Thiele, Wilko ;
Sleeman, Jonathan P. .
JOURNAL OF BIOTECHNOLOGY, 2006, 124 (01) :224-241
[35]  
Witte D, 2002, ANTICANCER RES, V22, P1463
[36]   Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis [J].
Wong, SY ;
Haack, H ;
Crowley, D ;
Barry, M ;
Bronson, RT ;
Hynes, RO .
CANCER RESEARCH, 2005, 65 (21) :9789-9798
1234